Universal screening for substance abuse at the time of parturition

American Journal of Obstetrics and Gynecology

Volumn 198, Issue 5, 2008, Pages

  Azadi, Ali ^a,b   Dildy III, Gary A ^a,c  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c St Mark's Hospital Salt Lake City   (United States)

Author keywords

drug abuse; pregnancy; universal screening

Indexed keywords

AMPHETAMINE DERIVATIVE; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; COCAINE; OPIATE DERIVATIVE; PHENCYCLIDINE; TETRAHYDROCANNABINOL;

ADULT; ARTICLE; DELIVERY; FEMALE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MASS SCREENING; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SUBSTANCE ABUSE; UNIVERSITY HOSPITAL;

ADULT; AGE FACTORS; AMPHETAMINE-RELATED DISORDERS; CESAREAN SECTION; COCAINE-RELATED DISORDERS; FEMALE; HIV INFECTIONS; HUMANS; LOUISIANA; MARIJUANA ABUSE; MASS SCREENING; PARITY; PARTURITION; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES; SUBSTANCE-RELATED DISORDERS; URBAN POPULATION;

EID: 42749091058     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2007.10.780     Document Type: Article

References (20)

1. Hansen R.L., Evans A.T., Gillogley K.M., Hughes C.S., and Krener P.G. Prenatal toxicology screening. J Perinatol 12 (1992) 220-224
2. Witter F.R., and Niebyl J.R. Marijuana use in pregnancy and pregnancy outcome. Am J Perinatol 7 (1990) 36-38
3. National Institute of Drug Abuse. Pregnancy and drug use trends. www.nid.nih.gov Accessed November 15, 2006
4. Richardson G.A., Hamel S.C., Goldschmidt L., and Day N.L. Growth of infants prenatally exposed to cocaine/crack: comparison of a prenatal care and a no prenatal care sample. Pediatrics 104 (1999) e18
5. Bandstra E.S., Morrow C.E., Anthony J.C., et al. Impact of cocaine exposure on intrauterine growth of full-term infants: impact of prenatal cocaine exposure. Pediatrics 108 (2001) 1309-1319
6. NIDA Research Report Series. Methamphetamine abuse and addictic. www.drugabuse.gov Accessed November 15, 2006
7. Ludlow J.P., Evans S.F., and Hulse G. Obstetric and perinatal outcomes in pregnancies associated with illicit substance abuse. Aust N Z J Obstet Gynaecol 44 (2004) 302-306
8. Won L., Bubula N., and Heller A. Fetal exposure to (+/-)-methylenedioxymethamphetamine in utero enhances the development and metabolism of serotonergic neurons in three-dimensional reaggregate tissue culture. Brain Res Dev Brain Res 137 (2002) 67-73
9. Golden N.L., Kuhnert B.R., Sokol R.J., Martier S., and Bagby B.S. Phencyclidine use during pregnancy. Am J Obstet Gynecol 148 (1984) 254-259
10. Delaney D.B., Larrabee K.D., and Monga M. Preterm premature rupture of the membranes associated with recent cocaine use. Am J Perinatol 14 (1997) 285-288
11. American College of Obstetricians and Gynecologists. Substance abuse in pregnancy. ACOG technical bulletin no. 195 (1994), American College of Obstetricians and Gynecologists, Washington, DC
12. Chasnoff I.J., Landress H.J., and Barrett M.E. The prevalence of illicit-drug or alcohol use during pregnancy and discrepancies in mandatory reporting in Pinellas County, Florida. N Engl J Med 322 (1990) 1202-1206
13. Chasnoff I.J., McGourty R.F., Bailey G.W., et al. The 4P's Plus screen for substance use in pregnancy: clinical application and outcomes. J Perinatol 25 (2005) 368-374
14. Ebrahim S.H., and Gfroerer J. Pregnancy-related substance use in the United States during 1996-1998. Obstet Gynecol 101 (2003) 374-379
15. In: Stratton K., Howe C., and Battaglia F. (Eds). Institute of medicine summary: fetal alcohol syndrome (1996), National Academy Press, Washington, DC
16. Strano-Rossi S. Methods used to detect drug abuse in pregnancy: a brief review. Drug Alcohol Depend 53 (1999) 257-271
17. Zuckerman B., Frank D.A., Hingson R., et al. Effects of maternal marijuana and cocaine use on fetal growth. N Engl J Med 320 (1989) 762-768
18. Matera C., Warren W.B., Moomjy M., Fink D.J., and Fox H.E. Prevalence of use of cocaine and other substances in an obstetric population. Am J Obstet Gynecol 163 (1990) 797-801
19. Keith L.G., MacGregor S., Friedell S., Rosner M., Chasnoff I.J., and Sciarra J.J. Substance abuse in pregnant women: recent experience at the Perinatal Center for Chemical Dependence of Northwestern Memorial Hospital. Obstet Gynecol 73 5 Pt 1 (1989) 715-720
20. Lipscomb G.H. The predictive value of routine urine drug screening in a high-risk obstetric population. J Maternal-Fetal Med 1 (1992) 117-120